Skip to Content
Merck

PROTBA

ProteoPrep® Blue Albumin & IgG Depletion Kit

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.56
UNSPSC Code:
41106500
Storage temp.:
2-8°C
Shipped in:
ambient
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


shipped in

ambient

Quality Level

storage temp.

2-8°C

Application

ProteoPrep® Blue Albumin & IgG Depletion Kit has been used:
  • to deplete serum samples from immunoglobulin (Ig) G and albumin
  • for albumin removal
  • for albumin and IgG removal
  • to deplete abundant plasma proteins for two-dimensional electrophoresis

Biochem/physiol Actions

ProteoPrep blue albumin depletion kit is designed to specifically remove albumin and IgG from 25 samples of human serum (25μL to 100μL) in preparation for two-dimensional electrophoresis (2DE). Albumin-depleted serum samples generated by this kit are in urea rather than salt-based buffers with little dilution, eliminating the need to precipitate the sample prior to performing 2DE.

Legal Information

ProteoPrep is a registered trademark of Merck KGaA, Darmstadt, Germany


signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 2 - Carc. 2 - Eye Dam. 1 - Flam. Liq. 3 - Repr. 2 - STOT SE 1

target_organs

Eyes,Central nervous system

Storage Class

3 - Flammable liquids

wgk

WGK 3



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Xi Liang et al.
Life science alliance, 4(10) (2021-08-26)
Sepsis is defined as an organ dysfunction syndrome and it has high mortality worldwide. This study analysed the proteome of serum from patients with sepsis to characterize the pathological mechanism and pathways involved in sepsis. A total of 59 patients
Yiting Li et al.
Methods in molecular biology (Clifton, N.J.), 818, 81-96 (2011-11-16)
The development of a sensitive, specific, and non-invasive approach for cancer detection will facilitate early detection and, hence, improve the outcome of individuals with known cancer predispositions. Proteomic profiling of blood emerges to be a logical choice of such non-invasive
Zeyu Sun et al.
Theranostics, 9(4), 1200-1214 (2019-03-15)
Chronic HBV infection (CHB) can lead to acute-on-chronic liver failure (HBV-ACLF) characterized by high mortality. This study aimed to reveal ACLF-related proteomic alterations, from which protein based diagnostic and prognostic scores for HBV-ACLF were developed. Methods: Ten healthy controls, 16



Global Trade Item Number

SKUGTIN
PROTBA-1KT04061836686963